ArticleFrontiers in oncology2021

Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy.

Marlon Wendell Athaydes Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.